Understanding Terminal 22q13 Deletions in Phelan/McDermid Syndrome
Author Information
Author(s): Maria Clara Bonaglia, Roberto Giorda, Silvana Beri, Cristina De Agostini, Francesca Novara, Marco Fichera, Lucia Grillo, Ornella Galesi, Annalisa Vetro, Roberto Ciccone, Maria Teresa Bonati, Sabrina Giglio, Renzo Guerrini, Sara Osimani, Susan Marelli, Claudio Zucca, Rita Grasso, Renato Borgatti, Elisa Mani, Cristina Motta, Massimo Molteni, Corrado Romano, Donatella Greco, Santina Reitano, Anna Baroncini, Elisabetta Lapi, Antonella Cecconi, Giulia Arrigo, Maria Grazia Patricelli, Chiara Pantaleoni, Stefano D'Arrigo, Daria Riva, Francesca Sciacca, Bernardo Dalla Bernardina, Leonardo Zoccante, Francesca Darra, Cristiano Termine, Emanuela Maserati, Stefania Bigoni, Emanuela Priolo, Armand Bottani, Stefania Gimelli, Frederique Bena, Alfredo Brusco, Eleonora di Gregorio, Irene Bagnasco, Ursula Giussani, Lucio Nitsch, Pierluigi Politi, Maria Luisa Martinez-Frias, Maria Luisa Martínez-Fernández, Nieves Martínez Guardia, Anna Bremer, Britt-Marie Anderlid, Orsetta Zuffardi
Primary Institution: Scientific Institute E. Medea
Hypothesis
What are the molecular mechanisms generating and stabilizing terminal deletions at chromosome 22q13?
Conclusion
The study reveals that terminal deletions at 22q13 can occur through various mechanisms and are associated with significant neurological deterioration.
Supporting Evidence
- SHANK3 gene haploinsufficiency is likely the cause of major neurological features associated with Phelan/McDermid syndrome.
- Distinct stabilizing events of the same terminal deletion can occur in different early embryonic cells.
- Progressive clinical deterioration was observed in adult patients over a span of forty years.
Takeaway
This study looks at a specific genetic problem that affects children and shows how it can lead to serious health issues as they grow up.
Methodology
The study involved molecular characterization of genomic rearrangements in patients with 22q13 deletions using various genetic analysis techniques.
Limitations
The study may not cover all possible genetic variations and their effects due to the complexity of the genetic landscape.
Participant Demographics
The study included 44 unrelated patients, comprising 26 females and 18 males, aged from birth to 47 years.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website